Searched over 200M research papers
10 papers analyzed
These studies suggest that low hemoglobin can be caused by iron deficiency anemia, variant hemoglobins, and is associated with various health risks such as cerebral hypoxia, poor birth outcomes, and higher morbidity in heart failure patients.
20 papers analyzed
Low hemoglobin, commonly referred to as anemia, is a condition frequently encountered in various clinical settings. It is essential for clinicians to understand the underlying causes to provide appropriate treatment. Anemia can result from numerous factors, including nutritional deficiencies, chronic diseases, and genetic conditions.
One of the most common causes of low hemoglobin is iron deficiency anemia. This condition is particularly prevalent among pre-menopausal women due to menstruation and pregnancy. Additionally, frequent blood donors are at risk because blood donation depletes iron stores, and the standard inter-donation interval may not be sufficient for recovery. Blood collection agencies face challenges in providing accurate information to donors about the causes of their low hemoglobin levels and in implementing programs to reduce deferrals.
Variant hemoglobins can also lead to low hemoglobin readings. These variants can cause discrepancies in pulse oximetry measurements, leading to unexpectedly low oxygen saturation (SpO2) readings despite normal arterial oxygen saturation (SaO2). This issue can result in unnecessary investigations and anxiety for patients.
Low hemoglobin levels in pregnant women are associated with adverse maternal and infant outcomes, including low birth weight, preterm birth, and increased perinatal mortality. Both low and high maternal hemoglobin levels can pose risks, highlighting the importance of monitoring and managing hemoglobin levels during pregnancy . Similarly, children with low hemoglobin levels may experience impaired growth and development, emphasizing the need for early intervention.
In the elderly, low hemoglobin levels are linked to increased morbidity and mortality. Anemia in this population can lead to higher in-hospital mortality rates, longer hospital stays, and higher readmission rates. Additionally, low hemoglobin levels in elderly men have been associated with an increased risk of developing depression .
Low hemoglobin levels can also impact cerebrovascular health. Studies in murine models have shown that anemia can cause cerebral hypoxia and impair blood-brain barrier function, leading to increased microglial activation and vascular permeability. These findings suggest that anemia may contribute to poor cerebrovascular outcomes and highlight the need for further research in this area.
Globally, there have been slight improvements in mean hemoglobin levels and a reduction in anemia prevalence among women and children from 1995 to 2011. However, significant regional disparities remain, with South Asia and Central and West Africa experiencing the lowest hemoglobin concentrations and highest anemia prevalence. Continued efforts are needed to address these disparities and improve hemoglobin levels in these regions.
Low hemoglobin levels can result from a variety of causes, including iron deficiency, genetic variants, and chronic diseases. The impact of anemia is far-reaching, affecting different populations in unique ways. Understanding the underlying causes and implementing targeted interventions are crucial for managing and mitigating the adverse effects of low hemoglobin. Further research is needed to explore the complex relationships between anemia, health outcomes, and regional disparities.
Most relevant research papers on this topic